Asthma affects 300 million people worldwide, yet the mechanism behind this pathology has only been partially elucidated. The documented connection between psychological stress and airway inflammation strongly suggests the involvement of the nervous system and its secreted mediators, including neuropeptides, on allergic respiratory disease. In this study, we show that neuropeptide Y (NPY), a prominent neurotransmitter, which release is strongly upregulated during stress, exacerbates allergic airway inflammation (AAI) in mice, via its Y1 receptor. Our data indicate that the development of AAI was associated with elevated NPY expression in the lung and that lack of NPY-mediated signalling in NPYKO mice or its Y1 receptor in Y1KO mice significantly improved AAI. In vivo, eosinophilia in the bronchoalveolar fluid as well as circulating immunoglobulin E in response to AAI, were significantly reduced in NPY-and Y1-deficient compared with wild-type mice. These changes correlated with a blunting of the Th2 immune profile that is characteristic for AAI, as shown by the decreased release of interleukin-5 during ex vivo re-stimulation of T cells isolated from the thoracic draining lymph nodes of NPY-or Y1-deficient mice subjected to AAI. Taken together this study demonstrates that signalling through Y1-receptors emerges as a critical pathway for the development of airway inflammation and as such potentially opens novel avenues for therapeutic intervention in asthma. Asthma is a chronic inflammation of the airways characterized by recurrent episodes of airway obstruction and associated with an inappropriate immune response to harmless environmental antigens. It is initiated and perpetuated by CD4 positive Th2 lymphocytes that secrete interleukin (IL)-4, 5 and 13, which are involved in the remodelling of airway epithelium, the hypereosinophilia and the secretion of Immunoglobulin E (IgE) by B lymphocytes. 1 The exact mechanisms involved in this immune response initiation still remains unclear. Recent evidence has highlighted the 'neuroimmune' crosstalk as a contributor to the development of the airway inflammation. 2 Indeed, a dysfunction of airway innervation can lead to asthma symptoms like breathlessness and cough. Neurotrophin and tackinin like bradykinin A and substance P, secreted by sensory nerves innervating the lung, directly contribute to the immune cell activation, bronchoconstriction and vasodilatation eventually leading to asthma development. 3 On the other hand, neural mediators can also have a protective role as levels of a-melanocyte-stimulating hormone, which is known to have an anti-inflammatory role and protect mice from allergic airway inflammation (AAI), is decreased in the lung of asthmatic patients. 4 However, the most convincing circumstantial evidence that the nervous system has a key role on asthma development is the fact that psychological stress worsens asthmatic syndrome. 2 Stress causes a highly complex response and thus what causes its worsened effects on asthma remains elusive. Stress is also k...